Particular features of steroid-induced osteoporosis;Besonderheiten der steroidinduzierten osteoporose

Orthopade

Volumn 36, Issue 8, 2007, Pages 708-713

  Hein, G E ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Bone destruction; Bone remodelling; Glucocorticoids; Inflammation; Osteoporosis

Indexed keywords

ALENDRONIC ACID; CALCIUM; ETIDRONIC ACID; RISEDRONIC ACID; VITAMIN D;

CLINICAL FEATURE; CORTICOSTEROID INDUCED OSTEOPOROSIS; DIAGNOSTIC PROCEDURE; HUMAN; PROPHYLAXIS; REVIEW; RISK FACTOR;

DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOCORTICOIDS; HUMANS; OSTEOPOROSIS;

EID: 36248981437     PISSN: 00854530     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00132-007-1117-0     Document Type: Review

References (27)

1. Amin S, Lavalley MP, Simms RW, Felson DT (2002) The comparative efficacy of drug therapies used for the management of corticosteroid-induced osteoporosis. A meta-regression. J Bone Miner Res 17: 1512-1526
2. Carnevale V, Romagnoli E, D'Èrasmo E (2004) Skeletal involvement in patients with diabetes mellitus. Diabetes Metab Res Rev 20: 196-204
3. Cepollaro C, Gonnelli S, Rottoli P et al. (2004) Bone ultrasonography in glucocorticoid-induced osteoporosis. Osteoporos Int; Inline Publication 1 October 2004
4. Deodhar AA (1996) Bone mass measurement and bone metabolism in rheumatoid arthritis: a review. Br J Rheumatol 35: 309-322
5. Nijs RN de, Jacobs JW, Bijlsma JW et al. (2001) Osteoporosis Working Group, Dutch Society for Rheumatology. Prevalence of vertebral deformities and sumptomatic vertebral fractures in corticosteroid treated patients with rheumatoid arthritis. Rheumatology 40: 1375-1383
6. Gruber GB (Hrsg) (1936) Nachruf auf Gustav Adolph Pommer. G. Fischer, Jena
7. Harada S, Rodan GA (2003) Control of osteoblast function and regulation of bone mass. Nature 423: 349-355
8. Hofbauer LC, Khosla S, Dunstan CR et al. (2000) The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 15: 2-12
9. Homik J, Cranney A, Shea B et al. (2001) Biphosphonates for steroid induced osteoporosis. The Cochrane Library; Issue 3: 1-17
10. Klaushofer K, Peterlik M (1996) Pathophysiology of osteoporosis. In: Bröll H, Dambacher MA (eds) Osteoporosis: A guide to diagnosis and treatment. Karger, Basel
11. Kummer L, Müller A, Machnik A, Hein GE (2005) Glukokortikoide scheinen bei später RA den Knorpelabbau eher zu verstärken. Z Rheumatol (Suppl 1) 64: 65
12. Lee TA, Weiss KB (2004) Fracture risk associated with inhaled corticosteroid use in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 169: 855-859
13. Michel BA (1991) Predictors of fractures in early rheumatoid arthritis. J Rheumatol 18: 804-808
14. Michel BA (1993) Fractures in rheumatoid arthritis: An evaluation of associated risk factors. J Rheumatol 20: 1666-1669
15. Oelzner P, Müller A, Franke S et al. (2006) Suppressiver Effekt von Glukokortikoiden auf die renale Elimination von Kollagencrosslinks bei RA-Patienten mit vergleichbarer entzündlicher Aktivität. Z Rheumatol (Suppl 1) 65: 33
16. Orstavik RE, Haugeberg G, Uhlig T et al. (2003) Vertebral deformities in 229 female patients with rheumatoid arthritis: Associations with clinical variables and bone mineral density. Arthritis Rheum 49: 355-360
17. Parfitt AM (1997) Quantum concept of bone remodeling and turnover. Implications for the pathogenesis of osteoporosis. Calcif Tissue Int 28: 1-5
18. Rehman Q, Lang T, Modin G, Lane NE (2002) Quantitative computed tomography of the lumbar spine, not dual x-ray absorptiometry, is an independent predictor of prevalent vertebral fractures in postmenopausal women with osteopenia receiving long-term glucocorticoid and hormone-replacement therapy. Arthritis Rheum 46: 1292-1297
19. Shenstone BD, Mahmoud R, Woodward R et al. (1994) Longitudinal bone mineral density changes in early rheumatoid arthritis. Br J Rheumatol 33: 541-545
20. Steinbruch M, Youket TE, Cohen S (2004) Oral glucocorticoid use is associated with an increased risk of fracture. Osteoporos Int 15: 323-328
21. Everdingen AA van, Siewertsz van Reesema DR, Jacobs JW, Bijlsma JW (2003) Low-dose glucocorticoids in early rheumatoid arthritis: Discordant effects on bone mineral density and fractures? Clin Exp Rheumatol 21: 155-160
22. Staa TP van (2006) The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis. Calcif Tissue Int 79: 129-137
23. Staa TP van, Geusens P, Pols HA et al. (2005) A simple score for estimating the long term risk of fracture in patients using oral glucocorticoids. QJM 98: 191-198
24. Staa TP van, Leufkens HGM, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a metaanalysis. Osteoporosis Int 13: 777-787
25. Staa TP van, Leufkens HGM, Abenhaim L et al. (2000) Use of oral corticosteroids an risk of fractures. J Bone Miner Res 15: 993-1000
26. Verhoeven AC, Boers M (1997) Limited bone loss due to corticosteroids: A systematic review of prospective studies in rheumatoid arthritis and other diseases. J Rheumatol 24: 1495-1503
27. Yamagishi S, Nakamura K, Inoue H (2005) Possible participation of advanced glycation endproducts in the pathogenesis of osteoporosis in diabetic patients. Med Hypotheses 65: 1013-1015